This study aims to evaluate the gene expression profile of FOXE1 mRNA in paired thyroid tumor and non-tumor tissue samples. Preliminary results from the first 10 paired samples show variation in FOXE1 gene expression levels between tumor and non-tumor tissues, with non-tumor tissue appearing to have higher FOXE1 expression compared to tumor tissue. Analysis of more sample pairs is ongoing, and FOXE1 expression levels will be compared to patient clinical data and tumor pathological characteristics. The results so far indicate there may be a profile of FOXE1 expression in thyroid cancer.
Targeting Telomerase and Topoisomerase-II by Natural Moieties: An Anti-Cancer...CrimsonpublishersCancer
One of the fundamental characteristic of tumor cell is to maintain the telomere length for continues progressive growth and survival. For the same, tumor cell has elevated levels of telomerase enzyme[1]. Telomerase is an unusual enzyme that acts on parts of chromosomes known as telomeres. Telomerase is a ribonucleoprotein and expressed in approximately 85% of different human cancers[2]. There is strong evidence for the existence of an important relationship between telomeres, telomerase and cancer [3]. Normal human cells progressively lose telomeres with each cell division until a few short telomeres become uncapped leading to a growth arrest, known as replicative aging. This phenomenon is totally absent in the cancer and cancer cells are adapted to have higher levels of telomerase enzyme which results in uncontrolled cell division. Attempts have also been made to develop telomere length-and telomerase-based diagnostic tools and anticancer therapeutics [4].
Zauderer, M.G., et al. Clinical Cancer Research, 2017.sellasq4
1. This randomized phase II trial evaluated the WT1 peptide vaccine galinpepimut-S combined with GM-CSF and Montanide in patients with malignant pleural mesothelioma after multimodality therapy.
2. The trial randomized 41 patients to galinpepimut-S plus adjuvants or adjuvants alone. The control arm was stopped early due to a futility analysis showing progression within 1 year in over 10 of the first 20 patients.
3. Trends toward improved progression-free survival (10.1 vs 7.4 months) and overall survival (22.8 vs 18.3 months) were observed in the vaccine arm compared to control, but the trial was
1) A study investigated vaccination with galinpepimut-S (GPS), a WT1 peptide mixture, in patients with multiple myeloma following autologous stem cell transplantation.
2) 19 patients received 6 doses of GPS post-transplant. This induced WT1-specific immune responses and improved survival outcomes.
3) Progression-free survival was 23.6 months for patients receiving GPS, compared to around 9 months for comparable historical controls receiving standard therapy alone. This suggests GPS improves survival in high-risk multiple myeloma patients after transplant.
The use of genetic engineering technology in animals has been associated with ethical issues, some of which relate to animal welfare. Discuss examples of genetically engineering animals and evaluate the ethical concerns of genetic engineering.
Cord Blood Mesenchymal Stem Cells Conditioned Media Suppress Epithelial Ovari...ijtsrd
MSC CM suppresses epithelial ovarian cancer cells in vitro in a concentration-dependent manner. When ovarian cancer cells were treated with MSC CM at concentrations of 100%, 75%, 50%, and 25% for 72 hours, cell morphology changes were observed including cell shrinkage, debris and reduced cell numbers compared to control. MTT assays showed reduced proliferation and Annexin V testing demonstrated increased early and late apoptosis. Cell cycle analysis found an increased sub-G1 phase, indicating apoptosis. Expression of embryonic stemness genes was also progressively suppressed in cancer cells treated with MSC CM compared to control. Therefore, MSC CM has potential as an ovarian cancer inhibitor by creating new treatment modalities.
This document summarizes the current immunotherapy and targeted therapy options for endometrial cancer. It discusses the biological and genetic background of endometrial cancer and its classification into types. The main immunotherapeutic options available include anti-cancer vaccines, immune checkpoint inhibitors that target molecules like PD-1 and PD-L1, and adoptive cell therapies. Several clinical trials of these therapies for endometrial cancer are ongoing based on their success in other cancer types. Identification of genetic alterations in endometrial cancer is leading to new targeted therapy options.
Compare the use of Lonza KGM Gold Bullet kit and Rheinwald and Green complete FAD medium in primary human epidermal keratinocytes culture and its applicability cells cultured by these medium in the construction of reconstituted skin equivalent model
This study aims to evaluate the gene expression profile of FOXE1 mRNA in paired thyroid tumor and non-tumor tissue samples. Preliminary results from the first 10 paired samples show variation in FOXE1 gene expression levels between tumor and non-tumor tissues, with non-tumor tissue appearing to have higher FOXE1 expression compared to tumor tissue. Analysis of more sample pairs is ongoing, and FOXE1 expression levels will be compared to patient clinical data and tumor pathological characteristics. The results so far indicate there may be a profile of FOXE1 expression in thyroid cancer.
Targeting Telomerase and Topoisomerase-II by Natural Moieties: An Anti-Cancer...CrimsonpublishersCancer
One of the fundamental characteristic of tumor cell is to maintain the telomere length for continues progressive growth and survival. For the same, tumor cell has elevated levels of telomerase enzyme[1]. Telomerase is an unusual enzyme that acts on parts of chromosomes known as telomeres. Telomerase is a ribonucleoprotein and expressed in approximately 85% of different human cancers[2]. There is strong evidence for the existence of an important relationship between telomeres, telomerase and cancer [3]. Normal human cells progressively lose telomeres with each cell division until a few short telomeres become uncapped leading to a growth arrest, known as replicative aging. This phenomenon is totally absent in the cancer and cancer cells are adapted to have higher levels of telomerase enzyme which results in uncontrolled cell division. Attempts have also been made to develop telomere length-and telomerase-based diagnostic tools and anticancer therapeutics [4].
Zauderer, M.G., et al. Clinical Cancer Research, 2017.sellasq4
1. This randomized phase II trial evaluated the WT1 peptide vaccine galinpepimut-S combined with GM-CSF and Montanide in patients with malignant pleural mesothelioma after multimodality therapy.
2. The trial randomized 41 patients to galinpepimut-S plus adjuvants or adjuvants alone. The control arm was stopped early due to a futility analysis showing progression within 1 year in over 10 of the first 20 patients.
3. Trends toward improved progression-free survival (10.1 vs 7.4 months) and overall survival (22.8 vs 18.3 months) were observed in the vaccine arm compared to control, but the trial was
1) A study investigated vaccination with galinpepimut-S (GPS), a WT1 peptide mixture, in patients with multiple myeloma following autologous stem cell transplantation.
2) 19 patients received 6 doses of GPS post-transplant. This induced WT1-specific immune responses and improved survival outcomes.
3) Progression-free survival was 23.6 months for patients receiving GPS, compared to around 9 months for comparable historical controls receiving standard therapy alone. This suggests GPS improves survival in high-risk multiple myeloma patients after transplant.
The use of genetic engineering technology in animals has been associated with ethical issues, some of which relate to animal welfare. Discuss examples of genetically engineering animals and evaluate the ethical concerns of genetic engineering.
Cord Blood Mesenchymal Stem Cells Conditioned Media Suppress Epithelial Ovari...ijtsrd
MSC CM suppresses epithelial ovarian cancer cells in vitro in a concentration-dependent manner. When ovarian cancer cells were treated with MSC CM at concentrations of 100%, 75%, 50%, and 25% for 72 hours, cell morphology changes were observed including cell shrinkage, debris and reduced cell numbers compared to control. MTT assays showed reduced proliferation and Annexin V testing demonstrated increased early and late apoptosis. Cell cycle analysis found an increased sub-G1 phase, indicating apoptosis. Expression of embryonic stemness genes was also progressively suppressed in cancer cells treated with MSC CM compared to control. Therefore, MSC CM has potential as an ovarian cancer inhibitor by creating new treatment modalities.
This document summarizes the current immunotherapy and targeted therapy options for endometrial cancer. It discusses the biological and genetic background of endometrial cancer and its classification into types. The main immunotherapeutic options available include anti-cancer vaccines, immune checkpoint inhibitors that target molecules like PD-1 and PD-L1, and adoptive cell therapies. Several clinical trials of these therapies for endometrial cancer are ongoing based on their success in other cancer types. Identification of genetic alterations in endometrial cancer is leading to new targeted therapy options.
Compare the use of Lonza KGM Gold Bullet kit and Rheinwald and Green complete FAD medium in primary human epidermal keratinocytes culture and its applicability cells cultured by these medium in the construction of reconstituted skin equivalent model
Review of Adoptive T-Cell ImmunotherapyLuke Brennan
1) Adoptive T-cell immunotherapy (ACT) involves extracting a patient's T-cells, modifying them to better recognize cancer cells, and reintroducing them to attack the cancer. Two main types are tumor-infiltrating lymphocytes (TILs) and engineered T-cells.
2) While promising, ACT faces challenges including T-cell inhibition by the immune system and cancer, toxicity from off-target autoimmunity, and short longevity of the modified T-cells. Additional research is needed to address these issues before ACT can become widely used.
3) The lengthy and resource-intensive cell culture and testing required for each patient also makes ACT costly currently, limiting its application to rare cancers
This document summarizes recent advances in immunotherapy for solid tumors. It discusses how immunotherapy has established itself as an effective treatment strategy, building on William Coley's pioneering work in the late 1800s using bacteria to elicit anti-tumor immune responses. The document outlines several key immunotherapy approaches, including immune checkpoint inhibitors, adoptive cellular therapy, strategies to enhance tumor immunogenicity like radiotherapy and oncolytic viruses, and cancer vaccines. It also discusses how tumor-infiltrating lymphocytes and immunoscore can help predict cancer prognosis and how the immune system interacts with tumors.
This document discusses immunotherapy strategies for metastatic renal cell carcinoma (RCC), including cytokines like interleukin-2 (IL-2) and interferon-α (IFN-α). It finds that high-dose IL-2 produces durable responses in a small percentage of selected patients, while IFN-α provides a modest survival benefit. Combining cytokines with targeted therapies may improve outcomes compared to cytokine monotherapy. Biomarkers like carbonic anhydrase IX expression and histologic subtype may help predict which patients are most likely to benefit from IL-2 therapy. Ongoing research aims to better select patients for IL-2 and explore combination therapies and novel immunotherapies to optimize treatment of metastatic RCC.
This study investigated combining two anti-cancer agents, T40214 and JG244, to target both the Stat3 and HIF-1α pathways in prostate cancer. T40214 inhibits phosphorylated Stat3 and JG244 inhibits HIF-1α. In vitro and in vivo experiments in human and murine prostate cancer models found that combination treatment with T40214 and JG244 significantly suppressed tumor growth more than either agent alone. Combination treatment also greatly increased apoptosis in the tumors compared to single agent treatments. The results suggest targeting both Stat3 and HIF-1α pathways together provides a more potent strategy for prostate cancer therapy.
Vorinostat combined with DNMTi epigenetically controls the proliferation of l...MustafaFathy6
This study evaluated the effects of combining the histone deacetylase inhibitor (HDACi) vorinostat with other chemotherapeutic drugs on lung cancer cells. Vorinostat alone and in combination with carboplatin was most effective at reducing cell viability of A549 lung cancer cells. Global DNA methylation patterns varied depending on the drug combinations, with vorinostat and carboplatin causing hypomethylation and vorinostat and cyclophosphamide resulting in hypermethylation. The results suggest that combining epigenetic and chemotherapeutic drugs may be more effective at controlling lung cancer proliferation than single agents alone. However, more experiments are needed to confirm these findings.
1) The company has a diversified pipeline including hematology and immunotherapy programs with multiple clinical trials in mid to late stages.
2) Their lead hematology candidate, GALE-401, is a controlled release formulation of anagrelide for the treatment of essential thrombocythemia that has demonstrated an improved safety profile over immediate release formulations in clinical trials to date.
3) Their immunotherapy programs include NeuVax for HER2-positive breast cancer, which has shown strong CD8+ T-cell responses in clinical trials both as a single agent and in combination with trastuzumab.
Clinical Genomics for Personalized Cancer Medicine: Recent Advances, Challeng...Yoon Sup Choi
I reviewed recent advances, challenges, and opportunities to implement clinical cancer genomics. Case studies of advanced systems, such as Foundation Medicine, MI-ONCOSEQ are introduced for benchmark. A few fundamental limitations to establish personalized oncology are also discussed.
hMSH2 Gly322Asp (rs4987188) Single nucleotide polymorphism and the risk of br...Agriculture Journal IJOEAR
Aim: Breast cancer is the most common cancer in women both in the developed and less developed world. The reported study was designed to explore associations between hMSH2 - Gly322Asp (1032G>A, rs4987188) single nucleotide polymorphism (SNP) and the risk of breast carcinoma in the Polish women.
Material and methods: Blood samples were obtained from women with breast cancer (n=225), treated at the Department of Oncological Surgery and Breast Diseases, Polish Mother’s Memorial Hospital – Research Institute between the years 2005 and 2012. A control group included 220 cancer-free women. Genomic DNA was isolated and the SNP Gly322Asp of hMSH2 was determined by High-Resolution Melter method. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for each genotype and allele.
Results: This study revealed that single nucleotide polymorphism Gly322Asp of hMSH2 is associated with both breast cancer risk and grading. Moreover, it can be linked with breast carcinoma tumor size and lymph node status. The Asp allele in patients may be a risk factor for breast carcinoma (OR 5.12; 95% CI 3.77 –6.97, p<.0001).
Conclusions: Gly322Asp single nucleotide polymorphism of hMSH2 may be a risk factor of breast cancer in the Polish women.
This document is a dissertation submitted for a BSc in Biological Sciences. It examines the implications of promoter hypermethylation of the GSTP1 gene in prostate carcinogenesis. It first provides background on prostate cancer development and factors influencing carcinogenesis like age, senescence, inflammation and oxidative stress. It then discusses DNA methylation and the GSTP1 gene. The dissertation aims to identify implications of GSTP1 hypermethylation in prostate cancer development and compare its effectiveness as a biomarker to PSA testing. It finds evidence that carcinogenic compounds may contribute to carcinogenesis and GSTP1 interacts with other cellular pathways. It also highlights issues with PSA testing and shows GSTP1 hypermethylation has
Geriatric Care at a Time of Accelerated Aging in the World Population and Eme...science journals
It is a well-known fact that the world population has been aging since mid-20th century. The number of older people aged 60 years and above has more than quadrupled since 1950’s and older people’s share of the world population reached 11.7 percent in 2013.
88 24-1853 051.812.955.17 folder to Tax ReturnSandro Suzart
This study examined the association between genetic polymorphisms in glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) and N-acetyltransferase 2 (NAT2) genes and the risk of developing asbestos-related pulmonary disorders in Finnish construction workers with high asbestos exposure. The risk of developing malignant mesothelioma or nonmalignant pulmonary disorders was not significantly associated with GSTM1 or GSTT1 genotypes. However, individuals with the NAT2 slow acetylator genotype had over a two-fold increased risk of developing asbestos-related pulmonary disorders compared to those with the fast acetylator genotype. Those with both the GSTM1 null genotype and NAT2 slow acetyl
We describe a comprehensive genomic characterization of 91 adrenocortical carcinoma specimens. Analysis identified several new ACC driver genes including PRKAR1A, RPL22, TERF2, CCNE1, and NF1. Genome-wide analysis revealed frequent occurrence of massive DNA loss followed by whole-genome doubling (WGD), associated with aggressive disease. WGD was identified as a hallmark of ACC progression, supported by increased TERT expression, decreased telomere length, and cell-cycle activation. Integrated molecular subtyping identified three ACC subtypes with distinct clinical outcomes and alterations, which could be captured by a 68-CpG DNA-methylation signature for clinical stratification.
This document discusses a study that tested whether combining nelfinavir and curcumin could increase the efficacy of docetaxel in treating castration-resistant prostate cancer. The study found that exposing castration-resistant prostate cancer cells to physiological concentrations of nelfinavir and curcumin significantly enhanced the cytotoxicity of low-dose docetaxel and induced apoptosis. Molecular studies showed this 3-drug combination more strongly suppressed the AKT survival pathway and induced ER stress pathways in cancer cells compared to normal cells. In mouse models, the 3-drug combination also significantly enhanced the antitumor effects of docetaxel compared to docetaxel alone. Therefore, combining nelfinav
This document summarizes several key molecular targets in cancer therapy and discusses how traditional Ayurvedic medicine may provide leads in developing treatments by modulating these targets. It describes major targets like the NF-κB, AP-1, and JAK-STAT pathways that are involved in processes like inflammation, proliferation, apoptosis, and drug resistance. The document then discusses how phytochemicals from plants used in Ayurveda have been shown to suppress many of these same targets and molecular pathways. It suggests Ayurvedic medicine could provide insights on new therapeutic agents if rediscovered in light of modern knowledge of cancer biology.
Cancer Precision Medicine Physiological Function of C MYC as Targeted Moleculeijtsrd
The genome represents a design for creating the body, with each one being different. In cancer genomic medicine, many genes are simultaneously examined using mainly cancer tissues the oncogene panel test , and gene mutations are revealed. Cancer treatments are then initiated according to each individual's constitution and medical condition based on gene mutations. A system for cancer genome medical treatment is currently being developed. In the treatment of several cancer types, the "oncogene test with an oncogene companion diagnosis" is already being performed as a standard test using cancer tissue to detect one or several gene mutations. Precision Medicine discovering unique therapies that treat an individual's cancer based on the specific abnormalities, i.e. germline or somatic mutations of their tumors. In this paper, we will explain the biological role of C MYC and emphasize the importance of C MYC as a target factor in cancer precision medicine. The functional activated C MYC for cell proliferation and tumorigenesis is potential candidate as anti oncogenic molecule. Takuma Hayashi | Ikuo Konishi "Cancer Precision Medicine: Physiological Function of C-MYC as Targeted Molecule" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-3 | Issue-5 , August 2019, URL: https://www.ijtsrd.com/papers/ijtsrd28030.pdfPaper URL: https://www.ijtsrd.com/medicine/other/28030/cancer-precision-medicine-physiological-function-of-c-myc-as-targeted-molecule/takuma-hayashi
Transcriptome Analysis of Spontaneous PDFJanaya Shelly
This document summarizes an analysis of gene expression in mouse lung tumors using RNA sequencing. Five mouse lung tumors - two spontaneous and three genetically engineered - were analyzed along with normal lung tissue. The top expressing genes in each tumor type were identified and their biological functions analyzed. Spontaneous tumors were associated with homeostatic processes while engineered tumors exhibited genes related to metastasis and immune response. The study aims to gain insights into lung cancer genetics using mouse models.
This study analyzed 264 gastric cancers for mutations in exons 9 and 20 of the PIK3CA gene. PIK3CA mutations were found in 42 cases (16%), all heterozygous missense mutations. The most common mutation was H1047R in exon 20 (62% of mutations) and the second most common was Q546K in exon 9 (9.5% of mutations). A meta-analysis of 27 publications found that the ratio of exon 20 to exon 9 mutations varied by cancer type, being highest in gastric cancer. The exon mutation selectivity is a signature of the cancer type.
This research paper examines the ability of the drug nelfinavir to overcome multidrug resistance in MCF-7/Dox breast cancer cells. The study finds that multiple exposures to physiologically achievable concentrations of nelfinavir can significantly decrease the doxorubicin IC50 in MCF-7/Dox cells by inhibiting P-glycoprotein expression and function, suppressing AKT signaling pathways, and inducing endoplasmic reticulum stress pathways. In mouse models carrying MCF-7/Dox tumor xenografts, combination treatment with nelfinavir and doxorubicin decreased tumor growth more than either drug alone. The results suggest that nelfinavir can overcome multiple drug resistance
Hepatocellular carcinoma (HCC) has always been a difficult medical problem for the increasing mortality rate. According to the World Health Organization (WHO), hepatocellular carcinoma (HCC) is the fourth-leading cause of cancer related deaths worldwide [1] and is considered as a highly refractory cancer. Surgery is the most effective treatment to HCC, but HCC is resistant to conventional chemotherapy. In recent years, immunotherapy has been attracting growing attention as a promising therapeutic method to HCC. Immunotherapies to HCC including chimeric antigen receptor T cells (CAR-T), immune checkpoint inhibitor and oncolytic virus have become research hotspots.
Ultrasound Technology as a Novel Treatment Strategy in Pancreatic Cancer_Crim...CrimsonpublishersCancer
Adenocarcinoma of the pancreas (PDAC) accounts for 2.4% of all cancers diagnosed and is the fourth leading cause of cancer death, with almost equal rates of incidence and mortality [1]. By 2030, pancreatic cancer is projected to be the second leading cause of cancer-related death [2], surpassing breast, prostate and colorectal cancer. The overall survival at 5 years of around 7.2% as the majority of patients present with advanced disease at diagnosis. Patients with localized disease are treated with surgery, with or without neoadjuvant chemotherapy/ radiotherapy, followed by adjuvant chemotherapy. The majority (around 80%) of patients are treated only with chemotherapy as they have an advanced disease. Patients are treated in the first line with gemcitabine-abraxane or Folfirinox and with Naliri plus 5FU in the second line. There have been few clinical advances in PDAC treatment over the last 20 years and chemotherapy is the only treatment option available for the majority of patients. These tumours are also resistant to many targeted therapies such as anti-EGFR therapy like cetuximab [3] due to the presence of a KRAS mutation in the majority of primary tumors. Personalized medicine strategies have not yet been established in pancreatic cancer as in other more common tumour types. Thus, novel anti-tumour strategies are an important clinical need in order to improve survival rates.
Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: effica...Enrique Moreno Gonzalez
This document summarizes a prospective, randomized, phase II clinical trial that evaluated the efficacy and safety of neoadjuvant chemotherapy with or without rh-endostatin for breast cancer. 68 patients received either 3 cycles of docetaxel and epirubicin (DE) chemotherapy alone or DE chemotherapy combined with rh-endostatin. The combination therapy showed a higher objective response rate of 91% compared to 68% for chemotherapy alone, with more complete responses but no increase in adverse effects. The combination appeared to work better in premenopausal patients and those with better performance status.
Review of Adoptive T-Cell ImmunotherapyLuke Brennan
1) Adoptive T-cell immunotherapy (ACT) involves extracting a patient's T-cells, modifying them to better recognize cancer cells, and reintroducing them to attack the cancer. Two main types are tumor-infiltrating lymphocytes (TILs) and engineered T-cells.
2) While promising, ACT faces challenges including T-cell inhibition by the immune system and cancer, toxicity from off-target autoimmunity, and short longevity of the modified T-cells. Additional research is needed to address these issues before ACT can become widely used.
3) The lengthy and resource-intensive cell culture and testing required for each patient also makes ACT costly currently, limiting its application to rare cancers
This document summarizes recent advances in immunotherapy for solid tumors. It discusses how immunotherapy has established itself as an effective treatment strategy, building on William Coley's pioneering work in the late 1800s using bacteria to elicit anti-tumor immune responses. The document outlines several key immunotherapy approaches, including immune checkpoint inhibitors, adoptive cellular therapy, strategies to enhance tumor immunogenicity like radiotherapy and oncolytic viruses, and cancer vaccines. It also discusses how tumor-infiltrating lymphocytes and immunoscore can help predict cancer prognosis and how the immune system interacts with tumors.
This document discusses immunotherapy strategies for metastatic renal cell carcinoma (RCC), including cytokines like interleukin-2 (IL-2) and interferon-α (IFN-α). It finds that high-dose IL-2 produces durable responses in a small percentage of selected patients, while IFN-α provides a modest survival benefit. Combining cytokines with targeted therapies may improve outcomes compared to cytokine monotherapy. Biomarkers like carbonic anhydrase IX expression and histologic subtype may help predict which patients are most likely to benefit from IL-2 therapy. Ongoing research aims to better select patients for IL-2 and explore combination therapies and novel immunotherapies to optimize treatment of metastatic RCC.
This study investigated combining two anti-cancer agents, T40214 and JG244, to target both the Stat3 and HIF-1α pathways in prostate cancer. T40214 inhibits phosphorylated Stat3 and JG244 inhibits HIF-1α. In vitro and in vivo experiments in human and murine prostate cancer models found that combination treatment with T40214 and JG244 significantly suppressed tumor growth more than either agent alone. Combination treatment also greatly increased apoptosis in the tumors compared to single agent treatments. The results suggest targeting both Stat3 and HIF-1α pathways together provides a more potent strategy for prostate cancer therapy.
Vorinostat combined with DNMTi epigenetically controls the proliferation of l...MustafaFathy6
This study evaluated the effects of combining the histone deacetylase inhibitor (HDACi) vorinostat with other chemotherapeutic drugs on lung cancer cells. Vorinostat alone and in combination with carboplatin was most effective at reducing cell viability of A549 lung cancer cells. Global DNA methylation patterns varied depending on the drug combinations, with vorinostat and carboplatin causing hypomethylation and vorinostat and cyclophosphamide resulting in hypermethylation. The results suggest that combining epigenetic and chemotherapeutic drugs may be more effective at controlling lung cancer proliferation than single agents alone. However, more experiments are needed to confirm these findings.
1) The company has a diversified pipeline including hematology and immunotherapy programs with multiple clinical trials in mid to late stages.
2) Their lead hematology candidate, GALE-401, is a controlled release formulation of anagrelide for the treatment of essential thrombocythemia that has demonstrated an improved safety profile over immediate release formulations in clinical trials to date.
3) Their immunotherapy programs include NeuVax for HER2-positive breast cancer, which has shown strong CD8+ T-cell responses in clinical trials both as a single agent and in combination with trastuzumab.
Clinical Genomics for Personalized Cancer Medicine: Recent Advances, Challeng...Yoon Sup Choi
I reviewed recent advances, challenges, and opportunities to implement clinical cancer genomics. Case studies of advanced systems, such as Foundation Medicine, MI-ONCOSEQ are introduced for benchmark. A few fundamental limitations to establish personalized oncology are also discussed.
hMSH2 Gly322Asp (rs4987188) Single nucleotide polymorphism and the risk of br...Agriculture Journal IJOEAR
Aim: Breast cancer is the most common cancer in women both in the developed and less developed world. The reported study was designed to explore associations between hMSH2 - Gly322Asp (1032G>A, rs4987188) single nucleotide polymorphism (SNP) and the risk of breast carcinoma in the Polish women.
Material and methods: Blood samples were obtained from women with breast cancer (n=225), treated at the Department of Oncological Surgery and Breast Diseases, Polish Mother’s Memorial Hospital – Research Institute between the years 2005 and 2012. A control group included 220 cancer-free women. Genomic DNA was isolated and the SNP Gly322Asp of hMSH2 was determined by High-Resolution Melter method. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for each genotype and allele.
Results: This study revealed that single nucleotide polymorphism Gly322Asp of hMSH2 is associated with both breast cancer risk and grading. Moreover, it can be linked with breast carcinoma tumor size and lymph node status. The Asp allele in patients may be a risk factor for breast carcinoma (OR 5.12; 95% CI 3.77 –6.97, p<.0001).
Conclusions: Gly322Asp single nucleotide polymorphism of hMSH2 may be a risk factor of breast cancer in the Polish women.
This document is a dissertation submitted for a BSc in Biological Sciences. It examines the implications of promoter hypermethylation of the GSTP1 gene in prostate carcinogenesis. It first provides background on prostate cancer development and factors influencing carcinogenesis like age, senescence, inflammation and oxidative stress. It then discusses DNA methylation and the GSTP1 gene. The dissertation aims to identify implications of GSTP1 hypermethylation in prostate cancer development and compare its effectiveness as a biomarker to PSA testing. It finds evidence that carcinogenic compounds may contribute to carcinogenesis and GSTP1 interacts with other cellular pathways. It also highlights issues with PSA testing and shows GSTP1 hypermethylation has
Geriatric Care at a Time of Accelerated Aging in the World Population and Eme...science journals
It is a well-known fact that the world population has been aging since mid-20th century. The number of older people aged 60 years and above has more than quadrupled since 1950’s and older people’s share of the world population reached 11.7 percent in 2013.
88 24-1853 051.812.955.17 folder to Tax ReturnSandro Suzart
This study examined the association between genetic polymorphisms in glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) and N-acetyltransferase 2 (NAT2) genes and the risk of developing asbestos-related pulmonary disorders in Finnish construction workers with high asbestos exposure. The risk of developing malignant mesothelioma or nonmalignant pulmonary disorders was not significantly associated with GSTM1 or GSTT1 genotypes. However, individuals with the NAT2 slow acetylator genotype had over a two-fold increased risk of developing asbestos-related pulmonary disorders compared to those with the fast acetylator genotype. Those with both the GSTM1 null genotype and NAT2 slow acetyl
We describe a comprehensive genomic characterization of 91 adrenocortical carcinoma specimens. Analysis identified several new ACC driver genes including PRKAR1A, RPL22, TERF2, CCNE1, and NF1. Genome-wide analysis revealed frequent occurrence of massive DNA loss followed by whole-genome doubling (WGD), associated with aggressive disease. WGD was identified as a hallmark of ACC progression, supported by increased TERT expression, decreased telomere length, and cell-cycle activation. Integrated molecular subtyping identified three ACC subtypes with distinct clinical outcomes and alterations, which could be captured by a 68-CpG DNA-methylation signature for clinical stratification.
This document discusses a study that tested whether combining nelfinavir and curcumin could increase the efficacy of docetaxel in treating castration-resistant prostate cancer. The study found that exposing castration-resistant prostate cancer cells to physiological concentrations of nelfinavir and curcumin significantly enhanced the cytotoxicity of low-dose docetaxel and induced apoptosis. Molecular studies showed this 3-drug combination more strongly suppressed the AKT survival pathway and induced ER stress pathways in cancer cells compared to normal cells. In mouse models, the 3-drug combination also significantly enhanced the antitumor effects of docetaxel compared to docetaxel alone. Therefore, combining nelfinav
This document summarizes several key molecular targets in cancer therapy and discusses how traditional Ayurvedic medicine may provide leads in developing treatments by modulating these targets. It describes major targets like the NF-κB, AP-1, and JAK-STAT pathways that are involved in processes like inflammation, proliferation, apoptosis, and drug resistance. The document then discusses how phytochemicals from plants used in Ayurveda have been shown to suppress many of these same targets and molecular pathways. It suggests Ayurvedic medicine could provide insights on new therapeutic agents if rediscovered in light of modern knowledge of cancer biology.
Cancer Precision Medicine Physiological Function of C MYC as Targeted Moleculeijtsrd
The genome represents a design for creating the body, with each one being different. In cancer genomic medicine, many genes are simultaneously examined using mainly cancer tissues the oncogene panel test , and gene mutations are revealed. Cancer treatments are then initiated according to each individual's constitution and medical condition based on gene mutations. A system for cancer genome medical treatment is currently being developed. In the treatment of several cancer types, the "oncogene test with an oncogene companion diagnosis" is already being performed as a standard test using cancer tissue to detect one or several gene mutations. Precision Medicine discovering unique therapies that treat an individual's cancer based on the specific abnormalities, i.e. germline or somatic mutations of their tumors. In this paper, we will explain the biological role of C MYC and emphasize the importance of C MYC as a target factor in cancer precision medicine. The functional activated C MYC for cell proliferation and tumorigenesis is potential candidate as anti oncogenic molecule. Takuma Hayashi | Ikuo Konishi "Cancer Precision Medicine: Physiological Function of C-MYC as Targeted Molecule" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-3 | Issue-5 , August 2019, URL: https://www.ijtsrd.com/papers/ijtsrd28030.pdfPaper URL: https://www.ijtsrd.com/medicine/other/28030/cancer-precision-medicine-physiological-function-of-c-myc-as-targeted-molecule/takuma-hayashi
Transcriptome Analysis of Spontaneous PDFJanaya Shelly
This document summarizes an analysis of gene expression in mouse lung tumors using RNA sequencing. Five mouse lung tumors - two spontaneous and three genetically engineered - were analyzed along with normal lung tissue. The top expressing genes in each tumor type were identified and their biological functions analyzed. Spontaneous tumors were associated with homeostatic processes while engineered tumors exhibited genes related to metastasis and immune response. The study aims to gain insights into lung cancer genetics using mouse models.
This study analyzed 264 gastric cancers for mutations in exons 9 and 20 of the PIK3CA gene. PIK3CA mutations were found in 42 cases (16%), all heterozygous missense mutations. The most common mutation was H1047R in exon 20 (62% of mutations) and the second most common was Q546K in exon 9 (9.5% of mutations). A meta-analysis of 27 publications found that the ratio of exon 20 to exon 9 mutations varied by cancer type, being highest in gastric cancer. The exon mutation selectivity is a signature of the cancer type.
This research paper examines the ability of the drug nelfinavir to overcome multidrug resistance in MCF-7/Dox breast cancer cells. The study finds that multiple exposures to physiologically achievable concentrations of nelfinavir can significantly decrease the doxorubicin IC50 in MCF-7/Dox cells by inhibiting P-glycoprotein expression and function, suppressing AKT signaling pathways, and inducing endoplasmic reticulum stress pathways. In mouse models carrying MCF-7/Dox tumor xenografts, combination treatment with nelfinavir and doxorubicin decreased tumor growth more than either drug alone. The results suggest that nelfinavir can overcome multiple drug resistance
Hepatocellular carcinoma (HCC) has always been a difficult medical problem for the increasing mortality rate. According to the World Health Organization (WHO), hepatocellular carcinoma (HCC) is the fourth-leading cause of cancer related deaths worldwide [1] and is considered as a highly refractory cancer. Surgery is the most effective treatment to HCC, but HCC is resistant to conventional chemotherapy. In recent years, immunotherapy has been attracting growing attention as a promising therapeutic method to HCC. Immunotherapies to HCC including chimeric antigen receptor T cells (CAR-T), immune checkpoint inhibitor and oncolytic virus have become research hotspots.
Ultrasound Technology as a Novel Treatment Strategy in Pancreatic Cancer_Crim...CrimsonpublishersCancer
Adenocarcinoma of the pancreas (PDAC) accounts for 2.4% of all cancers diagnosed and is the fourth leading cause of cancer death, with almost equal rates of incidence and mortality [1]. By 2030, pancreatic cancer is projected to be the second leading cause of cancer-related death [2], surpassing breast, prostate and colorectal cancer. The overall survival at 5 years of around 7.2% as the majority of patients present with advanced disease at diagnosis. Patients with localized disease are treated with surgery, with or without neoadjuvant chemotherapy/ radiotherapy, followed by adjuvant chemotherapy. The majority (around 80%) of patients are treated only with chemotherapy as they have an advanced disease. Patients are treated in the first line with gemcitabine-abraxane or Folfirinox and with Naliri plus 5FU in the second line. There have been few clinical advances in PDAC treatment over the last 20 years and chemotherapy is the only treatment option available for the majority of patients. These tumours are also resistant to many targeted therapies such as anti-EGFR therapy like cetuximab [3] due to the presence of a KRAS mutation in the majority of primary tumors. Personalized medicine strategies have not yet been established in pancreatic cancer as in other more common tumour types. Thus, novel anti-tumour strategies are an important clinical need in order to improve survival rates.
Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: effica...Enrique Moreno Gonzalez
This document summarizes a prospective, randomized, phase II clinical trial that evaluated the efficacy and safety of neoadjuvant chemotherapy with or without rh-endostatin for breast cancer. 68 patients received either 3 cycles of docetaxel and epirubicin (DE) chemotherapy alone or DE chemotherapy combined with rh-endostatin. The combination therapy showed a higher objective response rate of 91% compared to 68% for chemotherapy alone, with more complete responses but no increase in adverse effects. The combination appeared to work better in premenopausal patients and those with better performance status.
This lecture was part of an educational course performed by the IATTGI group this August in Buenos Aires and describes novel targets and novel drugs in hepatocellular carcinoma.
This study examined the effects of combined inhibition of the Src family kinases (SFK) and insulin-like growth factor 1 receptor (IGF-1R) pathways in prostate cancer (PCa) cells and in mouse models. Dual inhibition of these pathways more potently inhibited PCa tumor growth in vitro and in vivo compared to inhibiting either pathway alone. The combination treatment more completely inhibited Akt phosphorylation and downstream survival pathways in the cancer cells. This suggests that targeting both the SFK and IGF-1R pathways may be a promising therapeutic strategy for PCa by blocking independent and cooperative processes important for tumor growth and survival.
The KRAS-Variant and miRNA Expression in RTOG Endometrial Cancer Clinical Tri...UCLA
The KRAS-variant may be a genetic marker of risk for type 2 endometrial cancers. In addition, tumor miRNA expression appears to be associated with patient age, lymphovascular invasion and the KRAS-variant, supporting the hypothesis that altered tumor biology can be measured by miRNA expression, and that the KRAS-variant likely impacts endometrial tumor biology.
This document summarizes a literature review on intra-tumoral lymphocytes (TIL) in breast cancer. The review found that assessing TIL is unnecessary in high-grade tumors but may be useful in intermediate-grade tumors. In neoadjuvant and adjuvant settings, CD3+ lymphocytes correlate with better response to chemotherapy. After chemotherapy, quantifying regulatory T cells (Treg; CD4+FOXP3+) is helpful as decreased levels correlate with better prognosis. While the role of TIL in breast cancer is established, the optimal methods for microscopic assessment and immunohistochemical subtyping of TIL remain unclear.
Clinic Correlation and Prognostic Value of P4HB and GRP78 Expression in Gastr...JohnJulie1
Prolyl 4-hydroxylase, beta polypeptide (P4HB) and Glucose‑regulated protein 78 (GRP78) represent for poor prognosis of various cancers, while rare research investigate correlation of them. This study aimed to explore correlation and prognostic value of them in gastric cancer (GC).
Clinic Correlation and Prognostic Value of P4HB and GRP78 Expression in Gastr...EditorSara
Prolyl 4-hydroxylase, beta polypeptide (P4HB) and Glucose‑regulated protein 78 (GRP78) represent for poor prognosis of various cancers, while rare research investigate correlation of them. This study aimed to explore correlation and prognostic value of them in gastric cancer (GC).
Clinic Correlation and Prognostic Value of P4HB and GRP78 Expression in Gastr...EditorSara
This study aimed to investigate the correlation between the expression of P4HB and GRP78 proteins and their prognostic value in gastric cancer. The study found that P4HB protein expression was positively correlated with GRP78 protein expression in gastric cancer tissue samples. High expression of either P4HB or GRP78 alone, or co-expression of both, was associated with poorer overall survival in patients. When considering postoperative adjuvant chemotherapy, high co-expression of P4HB and GRP78 only represented an unfavorable prognosis in patients who received chemotherapy. A prognostic nomogram incorporating P4HB and GRP78 expression and other factors was developed and found to have better predictive performance than the TNM staging system.
Clinic Correlation and Prognostic Value of P4HB and GRP78 Expression in Gastr...NainaAnon
Prolyl 4-hydroxylase, beta polypeptide (P4HB) and Glucose‑regulated protein 78 (GRP78) represent for poor prognosis of various cancers, while rare research investigate correlation of them. This study aimed to explore correlation and prognostic value of them in gastric cancer (GC).
A normal cell can be transformed into a cancerous cell. Discuss the therapeutic strategies that are employed to target the cellular transformation process for cancer prevention and treatment.
1) The combination of the HDAC inhibitor entinostat and anti-PD-1 antibody significantly inhibited tumor growth in a murine renal cell carcinoma model more than either treatment alone.
2) Analysis of the tumor microenvironment showed the combination increased CD8+ T cells and decreased regulatory T cells, resulting in an increased CD8+/Treg ratio.
3) The combination also increased two subsets of myeloid-derived suppressor cells in the tumor and altered tumor-associated macrophages and CD8+ T cells, indicating changes to the immune cell populations in the microenvironment.
Gastric Cancer and the Role of Hedgehog- Interacting Protein One as a Prognos...CrimsonpublishersCancer
Hedgehog (Hh) signaling has been linked to foregut development since its initial discovery in Drosophila. The mammalian genome expresses three (3) Hh ligands, with sonic hedgehog (Shh) level of expression is highest in the mucosa of the embryonic and adult foregut. Hedgehog signaling aberrant activation is associated with pathological consequences in a range of human cancer. Hedgehog signaling is of pivotal role in homeostasis, neoplastic transformation, and gastrointestinal cancer development. The ability to track these cell types in tumor micro-environment broadens options for the more efficient screening of subjects predisposed to eventually developing gastric cancer as well as to expand opportunities for prophylactic therapy once atrophic gastritis develops. The Hedgehog-interacting protein (HHIP) gene is an essential homolog for multiple developmental processes. However, the expression and clinical correlation of HHIP in gastric cancer (GC) has not thoroughly been investigated. There is need to explore the expression of HHIP in gastric cancer (GC) and evaluate its clinicopathological and functional correlation.
A normal cell can be transformed into a cancerous cell. Discuss the therapeutic strategies that are employed to target the cellular transformation process for cancer prevention and treatment.
Mechanisms and applications of apoptosis based and molecularDrSatyabrataSahoo
The document discusses apoptosis, or programmed cell death, and strategies for targeting apoptosis for disease treatment. It notes that apoptosis is regulated by various molecules and caspase activation plays a key role. Cancer development involves evading apoptosis, so targeting apoptosis is a promising strategy. Several therapeutic agents targeting different apoptosis regulators are in clinical trials, alone or in combination with chemotherapy. Strategies include targeting caspases, death receptor signaling, or modulating other apoptosis components. Successful targeting of apoptosis has been demonstrated in experimental models and holds potential for treating various diseases.
The document discusses enhancing quality of life as an important goal for cancer treatment. It notes that while treatments have increased survival rates, they can also cause chronic health issues for survivors that reduce quality of life. More research is needed to better understand and prevent these toxic side effects, through identifying biomarkers and mitigation strategies. The authors call for increased priority and resources for quality of life research to both improve existing treatments and enable more patients to benefit from new therapies.
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...eshaasini
This meta-analysis examined 27 studies to determine if serum thymidine kinase 1 concentration (STK1p) can provide benefit for risk assessment of gastric neoplasm progression to gastric carcinoma (GC) and for evaluating GC treatment effects. The studies included 1,909 GC patients, 1,229 gastric neoplasm patients, and 2,260 tumor-free individuals. The results showed that STK1p levels increased significantly from tumor-free to superficial gastritis to chronic gastritis to atrophic gastritis to gastric ulcer to GC. STK1p levels in 251 GC patients declined significantly by 66% one month after surgery compared to pre-surgery levels. This suggests that STK1p has
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...semualkaira
Human Thymidine kinase 1 (hTK1), a key enzyme involved in the DNA synthesis during S-phase of the cell cycle and upregulation of cell proliferation, thus it is reliable tumor proliferating biomarker for assessment of tumor proliferation rate in serum and in tissue in oncology. This meta-analysis is investigation whether the serum TK1 concentration(STK1p)based on hTK1-IgY-polyclonal-antibody can provide a benefit for risk assessment from gastric neoplasm progression to gastric carcinoma (GC) as well as for evaluation of treatment effect in GC.
Similar to In Vitro Evaluation of Biofield Treatment on Cancer Biomarkers Involved in Endometrial and Prostate Cancer Cell Lines (20)
Evaluation of Biofield Treatment on Physical and Structural Properties of Bro...albertdivis
Bronze, a copper-tin alloy, widely utilizing in manufacturing of gears, bearing, and packing technologies due to its versatile physical, mechanical, and chemical properties. The aim of the present work was to evaluate the effect of biofield treatment on physical and structural properties of bronze powder.
Influence of Biofield Treatment on Physical and Structural Characteristics of...albertdivis
Barium oxide (BaO) and zinc sulfide (ZnS) are well known for their applications in electrical, optical and chemical industries. The present study was aimed to evaluate the impact of biofield treatment on the structural and physical properties of BaO and ZnS powder.
Physical and Structural Characterization of Biofield Treated Imidazole Deriva...albertdivis
The Aim of present study was to evaluate the impact of biofield treatment on two imidazole derivatives (i.e., imidazole and 2-methylimidazole) by various analytical methods.
Antibiogram and Genotypic Analysis using 16S rDNA after Biofield Treatment on...albertdivis
The aim of this study was to evaluate the effect of Mr. Trivedi’s biofield energy treatment on M. morganii in the lyophilized as well as revived state for antimicrobial susceptibility pattern, biochemical characteristics, biotype number and genotype.
Characterization of Physical, Spectral and Thermal Properties of Biofield Tre...albertdivis
The objective of the present research was to investigate the influence of biofield treatment on physical, spectral and thermal properties of 1,2,4-triazole.
Evaluation of Phenotyping and Genotyping Characterization of Serratia marcesc...albertdivis
The present study was aimed to evaluate the impact of biofield treatment on phenotyping and genotyping characteristics such as antimicrobial susceptibility, biochemical reactions, biotype, DNA polymorphism, and phylogenetic relationship of S. marcescens (ATCC 13880).
Effect of Biofield Treatment on Phenotypic and Genotypic Characteristic of Pr...albertdivis
The Present study was designed to evaluate the effect of biofield treatment on P. rettgeri against antimicrobial susceptibility, biochemical reaction pattern, biotype number, and 16S rDNA sequence.
Antimicrobial Susceptibility Pattern, Biochemical Characteristics and Biotypi...albertdivis
The current study was attempted to investigate the effect of biofield treatment on Salmonella paratyphi A (S. paratyphi A) in terms of antimicrobial susceptibility assay, biochemical characteristics and biotyping.
Physical, Thermal and Spectroscopic Studies on Biofield Treated p-Dichloroben...albertdivis
This research article studied the effects of biofield treatment on para-dichlorobenzene (p-DCB). p-DCB is widely used as a chemical intermediate but has some limitations. X-ray diffraction analysis found an increase in crystallite size of the treated sample compared to the control. Differential scanning calorimetry analysis showed a reduction in the latent heat of fusion and melting point of the treated p-DCB. Thermogravimetric analysis found an increase in the maximum weight loss temperature of the treated sample, indicating increased thermal stability. However, UV-visible spectroscopy found no changes in the structural properties of the treated p-DCB. Overall, the study found that biofield treatment
Antibiogram Typing and Biochemical Characterization of Klebsiella pneumoniae ...albertdivis
The Aim of the present study was to determine the impact of Mr. Trivedi’s biofield treatment on four MDR clinical lab isolates (LS) of K. pneumoniae (LS 2, LS 6, LS 7, and LS 14).
Phenotypic and Biotypic Characterization of Klebsiella oxytoca: An Impact of ...albertdivis
Klebsiella oxytoca (K. oxytoca) is a Gram-negative microbe generally associated with community and hospitalacquired infections. Due to its clinical significance, we evaluated the effect of biofield treatment on phenotype and biotype characteristics of K. oxytoca (ATCC 43165).
Spectroscopic Characterization of Disodium Hydrogen Orthophosphate and Sodium...albertdivis
Disodium hydrogen orthophosphate is a water soluble white powder widely used as pH regulator and saline laxative. The sodium nitrate is a highly water soluble white solid, used in high blood pressure, dentinal hypersensitivity, and production of fertilizers. The present study was aimed to investigate the impact of biofield treatment on spectral properties of disodium hydrogen orthophosphate and sodium nitrate.
An Impact of Biofield Treatment: Antimycobacterial Susceptibility Potential U...albertdivis
The aim was to evaluate the impact of biofield treatment modality on mycobacterial strains in relation to antimycobacterials susceptibility. Mycobacterial sensitivity was analysed using 12 B BACTEC vials on the BACTEC 460 TB machine in 39 lab isolates (sputum samples) from stored stock cultures.
Fourier Transform Infrared and Ultraviolet-Visible Spectroscopic Characteriza...albertdivis
Ammonium acetate and ammonium chloride are the white crystalline solid inorganic compounds having wide application in synthesis and analytical chemistry. The aim of present study was to evaluate the impact of biofield treatment on spectral properties of inorganic salt like ammonium acetate and ammonium chloride.
Characterization of Physical and Structural Properties of Aluminium Carbide P...albertdivis
Aluminium carbide (Al4C3) has gained extensive attention due to its abrasive and creep resistance properties. Aim of the present study was to evaluate the impact of biofield treatment on physical and structural properties of Al4C3 powder.
Structural and Physical Properties of Biofield Treated Thymol and Mentholalbertdivis
Thymol and menthol are naturally occurring plant derived compounds, which have excellent pharmaceutical and antimicrobial applications. The aim of this work was to evaluate the impact of biofield energy on physical and structural characteristics of thymol and menthol.
Spectroscopic Characterization of Biofield Treated Metronidazole and Tinidazolealbertdivis
Metronidazole and tinidazole are widely used antimicrobial drugs against Gram-negative and Gram-positive anaerobic bacteria. The present study was aimed to evaluate the impact of biofield treatment on metronidazole and tinidazole using FT-IR and UV spectroscopy.
Potential Impact of BioField Treatment on Atomic and Physical Characteristics...albertdivis
Magnesium (Mg), present in every cell of all living organisms, is an essential nutrient and primarily responsible for catalytic reaction of over 300 enzymes. The aim of present study was to evaluate the effect of biofield treatment on atomic and physical properties of magnesium powder.
The ability to recreate computational results with minimal effort and actionable metrics provides a solid foundation for scientific research and software development. When people can replicate an analysis at the touch of a button using open-source software, open data, and methods to assess and compare proposals, it significantly eases verification of results, engagement with a diverse range of contributors, and progress. However, we have yet to fully achieve this; there are still many sociotechnical frictions.
Inspired by David Donoho's vision, this talk aims to revisit the three crucial pillars of frictionless reproducibility (data sharing, code sharing, and competitive challenges) with the perspective of deep software variability.
Our observation is that multiple layers — hardware, operating systems, third-party libraries, software versions, input data, compile-time options, and parameters — are subject to variability that exacerbates frictions but is also essential for achieving robust, generalizable results and fostering innovation. I will first review the literature, providing evidence of how the complex variability interactions across these layers affect qualitative and quantitative software properties, thereby complicating the reproduction and replication of scientific studies in various fields.
I will then present some software engineering and AI techniques that can support the strategic exploration of variability spaces. These include the use of abstractions and models (e.g., feature models), sampling strategies (e.g., uniform, random), cost-effective measurements (e.g., incremental build of software configurations), and dimensionality reduction methods (e.g., transfer learning, feature selection, software debloating).
I will finally argue that deep variability is both the problem and solution of frictionless reproducibility, calling the software science community to develop new methods and tools to manage variability and foster reproducibility in software systems.
Exposé invité Journées Nationales du GDR GPL 2024
The technology uses reclaimed CO₂ as the dyeing medium in a closed loop process. When pressurized, CO₂ becomes supercritical (SC-CO₂). In this state CO₂ has a very high solvent power, allowing the dye to dissolve easily.
The binding of cosmological structures by massless topological defectsSérgio Sacani
Assuming spherical symmetry and weak field, it is shown that if one solves the Poisson equation or the Einstein field
equations sourced by a topological defect, i.e. a singularity of a very specific form, the result is a localized gravitational
field capable of driving flat rotation (i.e. Keplerian circular orbits at a constant speed for all radii) of test masses on a thin
spherical shell without any underlying mass. Moreover, a large-scale structure which exploits this solution by assembling
concentrically a number of such topological defects can establish a flat stellar or galactic rotation curve, and can also deflect
light in the same manner as an equipotential (isothermal) sphere. Thus, the need for dark matter or modified gravity theory is
mitigated, at least in part.
Current Ms word generated power point presentation covers major details about the micronuclei test. It's significance and assays to conduct it. It is used to detect the micronuclei formation inside the cells of nearly every multicellular organism. It's formation takes place during chromosomal sepration at metaphase.
ESR spectroscopy in liquid food and beverages.pptxPRIYANKA PATEL
With increasing population, people need to rely on packaged food stuffs. Packaging of food materials requires the preservation of food. There are various methods for the treatment of food to preserve them and irradiation treatment of food is one of them. It is the most common and the most harmless method for the food preservation as it does not alter the necessary micronutrients of food materials. Although irradiated food doesn’t cause any harm to the human health but still the quality assessment of food is required to provide consumers with necessary information about the food. ESR spectroscopy is the most sophisticated way to investigate the quality of the food and the free radicals induced during the processing of the food. ESR spin trapping technique is useful for the detection of highly unstable radicals in the food. The antioxidant capability of liquid food and beverages in mainly performed by spin trapping technique.
Or: Beyond linear.
Abstract: Equivariant neural networks are neural networks that incorporate symmetries. The nonlinear activation functions in these networks result in interesting nonlinear equivariant maps between simple representations, and motivate the key player of this talk: piecewise linear representation theory.
Disclaimer: No one is perfect, so please mind that there might be mistakes and typos.
dtubbenhauer@gmail.com
Corrected slides: dtubbenhauer.com/talks.html
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...Travis Hills MN
Travis Hills of Minnesota developed a method to convert waste into high-value dry fertilizer, significantly enriching soil quality. By providing farmers with a valuable resource derived from waste, Travis Hills helps enhance farm profitability while promoting environmental stewardship. Travis Hills' sustainable practices lead to cost savings and increased revenue for farmers by improving resource efficiency and reducing waste.
hematic appreciation test is a psychological assessment tool used to measure an individual's appreciation and understanding of specific themes or topics. This test helps to evaluate an individual's ability to connect different ideas and concepts within a given theme, as well as their overall comprehension and interpretation skills. The results of the test can provide valuable insights into an individual's cognitive abilities, creativity, and critical thinking skills
Authoring a personal GPT for your research and practice: How we created the Q...Leonel Morgado
Thematic analysis in qualitative research is a time-consuming and systematic task, typically done using teams. Team members must ground their activities on common understandings of the major concepts underlying the thematic analysis, and define criteria for its development. However, conceptual misunderstandings, equivocations, and lack of adherence to criteria are challenges to the quality and speed of this process. Given the distributed and uncertain nature of this process, we wondered if the tasks in thematic analysis could be supported by readily available artificial intelligence chatbots. Our early efforts point to potential benefits: not just saving time in the coding process but better adherence to criteria and grounding, by increasing triangulation between humans and artificial intelligence. This tutorial will provide a description and demonstration of the process we followed, as two academic researchers, to develop a custom ChatGPT to assist with qualitative coding in the thematic data analysis process of immersive learning accounts in a survey of the academic literature: QUAL-E Immersive Learning Thematic Analysis Helper. In the hands-on time, participants will try out QUAL-E and develop their ideas for their own qualitative coding ChatGPT. Participants that have the paid ChatGPT Plus subscription can create a draft of their assistants. The organizers will provide course materials and slide deck that participants will be able to utilize to continue development of their custom GPT. The paid subscription to ChatGPT Plus is not required to participate in this workshop, just for trying out personal GPTs during it.
2. Citation: Trivedi MK, Patil S, Shettigar H, Gangwar M, Jana S (2015) In Vitro Evaluation of Biofield Treatment on Cancer Biomarkers Involved in
Endometrial and Prostate Cancer Cell Lines. J Cancer Sci Ther 7: 253-257. doi:10.4172/1948-5956.1000358
J Cancer Sci Ther
ISSN: 1948-5956 JCST, an open access journal Volume 7(7) 253-257 (2015) - 254
control and treated sample to observe the impact of biofield treatment
on concentration of biomarkers (IL-2R, IL-6, TNF-α, PSA, and FPSA)
[28]. ELISA principle started with capturing antibody, specific for a
protein of interest, coated onto the wells of microplates. Control and
biofield treated cell lysate samples were diluted and pipetted into the 96
micro wells titer plate. Buffer was added into each well and mixed gently
for 30 seconds. The plate was covered and incubated for 60 minutes
at room temperature as per manufacturer’s instruction. Removed the
incubation mixture from all wells followed by washing with distilled
water for five times. During this incubation, protein of interest i.e.,
antigen (TNF-α, IL-6, PSA, FPSA, and IL-2R) attached to the antibody.
A secondary antibody was added to the wells after washing with buffer,
which bound to immobilized protein captured during first incubation.
Excess antibody was removed by washing with the help of wash buffer.
After that, enzyme conjugate was added into each well, mixed gently for
10 seconds followed by incubation for 60 minutes at room temperature.
A specific substrate solution was added into the well which was
converted by the enzyme to form a detectable color. The intensity of
the color produced was read spectrophotometrically which was directly
proportional to the concentration of protein of interest present in the
cell line samples. Control and treated sample values were recorded
in picogram per milliliter (IL-6 and TNF-α: pg/ml), nano gram per
milliliter(PSAandFPSA:ng/ml),andunitpermilliliter(IL-2R-U/ml)[29].
Results and Discussion
Since prostate and endometrium cancers are most critical
medical problems affecting major population, physician suggests
chemoprevention strategies to reduce the incidence and mortality rate.
However, there are scientific evidence and large number of in vitro
studies already reported for biofield treatment and its effect in cancer
cell lines [19,20]. The present study aimed to examine Mr. Trivedi’s
biofield treatment on cancer biomarkers associated with endometrium
and prostate cancer. Previous studies indicated that there were an
inhibitory effect of biofield energy on metastasis and immune responses
on cancer cell models [30-33].
Results of control and treatment group, at day 10 are summarized
in Table 1. In case of endometrium cell line, 12% reduction in IL-6
concentration was found in biofield treated group as compared to
control. After biofield treatment, decreased level of IL-6 (3.52 pg/
ml) was reported as compared to control (4.0 pg/ml). A highly
significant increase in TNF-α (385%) level was estimated in biofield
treated endometrium cell line (20.5 pg/ml) as compared to control
(4.23 pg/ml). A high increase in TNF-α level might be its association
and binding with several other cells such as endothelial cells, which
results in its high expression after biofield treatment as compared as
control [34]. However, level of PSA, FPSA, and IL-2R did not show
any alteration after biofield treatment as compared to control. In
endometrial adenocarcinoma, cytokines promote tumor development
by angiogenesis and mediating cell invasion. TNF-α, pro-inflammatory
cytokine biomarker exists as both soluble and membrane-integrated
proteins activates signaling pathways, and is expressed on surface
epithelium in cancer and endometrial adenocarcinoma. It promotes
angiogenesis by the activation of NF-κB, a protein complex [35]. Apart
from TNF-α, IL-6 is another pro-inflammatory cytokines whose level is
upregulated in endometrial adenocarcinoma, which is associated with
a poor prognosis [36]. Cancer research now proofed that dysregulation
in immune system contributes to metastasis and lead to cell death.
However, cancer progression is indicative by chronic inflammation
which enhances angiogenesis and tissue metabolism results in cytokines
release. Therefore, a significant alteration of important inflammatory
(NCCAM), now defined biofield therapies in the subcategory of energy
therapies as one of the five complementary medicine domains. Biofield
is the name given to the electromagnetic field that permeates and
surrounds living organisms. It is the scientifically preferred term for
the biologically produced electromagnetic and subtle energy field that
provides regulatory and communication functions within the organism.
Recent studies on cancer research suggest that instead of using other
complementary and alternate medicine, cancer patients received
highest benefit with energy medicine [15]. The concept of human
bioenergy has its origin thousands of year back, till date many recent
biofield therapies are in practice for their possible therapeutic potentials
such as enhanced personal well-being in cancer patient [16], improved
functional ability of arthritis patient [17], decreased pain and anxiety
[18]. However, many other significant inhibitory effects on the cancer
cell model have been published which suggest that biofield treatment
could be a new and effective treatment approach for cancer [19,20]. Mr.
Mahendra Trivedi’s unique biofield treatment (The Trivedi’s effect®) has
significantly studied in different fields. In agriculture, change on growth,
characteristics, and yield of plants were reported after biofield treatment
[21,22]. It has also significantly altered the crystalline and powder
characteristics of metals [23,24] and transformation of biofield energy
has considerably altered the genotype and phenotypes of pathogenic
microbes against antimicrobials [25-27]. This experiment was designed
to evaluate the impact of biofield treatment on cancer biomarkers in
endometrium and prostate cancer cell lines. Concentration of cytokines
(i.e. TNF-α and IL-6), interleukin-2 receptor (IL-2R), prostate specific
antigen (PSA), and free prostate specific antigen (FPSA) were estimated
by using ELISA assay on day 10 after biofield treatment as compared to
control.
Materials and Methods
Experimental design
Endometrium and prostate cancer cell lines, as stock stored cultures
were procured for the experiment from department of laboratory
medicine, P.D. Hinduja National Hospital & Medical Research Centre,
Mumbai. Enzyme-Linked Immuno-Sorbant Assay (ELISA) method
was used for estimation of cytokines levels. Important cancer diagnostic
biomarkers such as IL-6, TNF-α, PSA (third generation), FPSA, and IL-
2R of control and treated samples were estimated using ELISA kit as per
manufacturer’s instruction.
Biofield treatment modalities
Endometrium and prostate cancer cell lines were taken for biofield
treatment. The first sets of both cancer cell line were considered as
control. No treatment was given to this set. The second sets of both
cancer cell line were handed over to Mr. Trivedi for biofield treatment
under laboratory condition. Mr. Trivedi provided the biofield
treatment through his energy transmission process to second sets of
samples without touching the samples. After treatment, both treated
samples were handed over in the same condition within an hour’s
time and stored at standard conditions for cytokines analysis after
10 days. Both the control and treated samples were analyzed after 10
days for difference in cancer biomarker as per the standard protocols.
An optimum precautionary measure were taken in estimation of IL-
6, TNF-α, PSA (third generation), FPSA, and IL-2R throughout the
experiment. The differences in tested cancer biomarkers level before
and after the treatment were noted.
Measurement of diagnostic cancer biomarkers
ELISA was performed as per the manufacturer’s instructions in
3. Citation: Trivedi MK, Patil S, Shettigar H, Gangwar M, Jana S (2015) In Vitro Evaluation of Biofield Treatment on Cancer Biomarkers Involved in
Endometrial and Prostate Cancer Cell Lines. J Cancer Sci Ther 7: 253-257. doi:10.4172/1948-5956.1000358
J Cancer Sci Ther
ISSN: 1948-5956 JCST, an open access journal Volume 7(7) 253-257 (2015) - 255
biomarkers (IL-6 and TNF-α) in endometrium cancer cell line suggests
that biofield treatment may affect metastasis, which results in alteration
of pleiotropic and multifunctional cytokine levels. This finding is the
first evidence that biofield therapy may alter the immune function in
endometrium cancer.
Biofield treatment on prostate cancer cell line showed a significant
reduction of as high as 98.8% in IL-6 level. After treatment, IL-6
concentrations showed less than 2 pg/ml as compared to control (165
pg/ml) in prostate cancer cells. Besides this, TNF-α level showed
an increase of 89.8% in biofield treated group (i.e.7.59 pg/ml) as
compared to control (less than 4.0 pg/ml). Slight increase in level of
PSA was observed in biofield treated prostate cell line as compared to
control (Table 1). However, level of FPSA and IL-2R did not show any
alteration after biofield treatment as compared to control. It suggests
that the biofield treatment has significant impact only on cytokines
level and not on receptors or antigens involved in metastasis. Above
cytokines have the major involvement in prostate cancer development
and elevated levels have been reported in prostate hyperplasia patients
[37]. IL-6 and TNF-α levels have strong correlation in serum with
hormone refractory prostate cancer as compared to normal cell [38].
Present study reported a significant reduction in IL-6 concentration
and an increase in TNF-α level in prostate and endometrium cancer
cell lines after biofield treatment (Figure 1). The result of the present
study supports the already published literature with significant biofield
effect on cancer cell lines. This study results are in agreement with the
reported data [31-33] and verify the influence of biofield treatment
on in vitro growth of prostate and endometrium cancer cell line with
respect to cancer biomarkers level in control and treated samples.
Current cancer therapies have certain limitations, which include
serious side effects such as enormous toxicity, altered immune system,
and high treatment cost etc. Many ancient biofield therapies for cancer
Figure 1: Percent change in cytokine level measured using ELISA assay on day 10 after biofield treatment in (a) endometrium cell line (b) prostate cell line.
S. No. Biomarker Endometrium cell line Prostate cell line
Control Treated % change Control Treated % change
1 IL-2R (U/ml) <50.0 <50.0 NC <50.0 <50.0 NC
2 IL-6 (pg/ml) 4.0 3.52 -12 165 < 2.0 -98.8
3 TNF-α (pg/ml) 4.23 20.5 385 < 4.0 7.59 89.8
4 PSA (ng/ml) < 0.003 < 0.003 NC < 0.003 0.003 NC
5 FPSA (ng/ml) < 0.05 < 0.05 NC < 0.05 < 0.05 NC
NC: No change; pg/ml: picogram per milliliter; ng/ml: Nano gram per milliliter; U/ml: Unit per milliliter; IL-2R: Interleukin-2 receptor; IL-6: Interleukin-6; TNF-α: Tumor necrosis
factor alpha; PSA: Prostate specific antigen; FPSA: Free prostate specific antigen.
Table 1: Effect of biofield treatment on cancer biomarker concentration in endometrium and prostate cancer cell lines.
4. Citation: Trivedi MK, Patil S, Shettigar H, Gangwar M, Jana S (2015) In Vitro Evaluation of Biofield Treatment on Cancer Biomarkers Involved in
Endometrial and Prostate Cancer Cell Lines. J Cancer Sci Ther 7: 253-257. doi:10.4172/1948-5956.1000358
J Cancer Sci Ther
ISSN: 1948-5956 JCST, an open access journal Volume 7(7) 253-257 (2015) - 256
are practiced around the world, among then Qigong therapy for cancer
is very popular and scientifically studied [39,40]. Therefore, Mr. Trivedi’s
biofield treatment could be an effective and alternate approach for
cancer with no side effects. Research on biofield therapies and its impact
on cancer growth have been continuously studied by researchers, which
might works as alternate and complementary medicine to prolong the
life of cancerous patients along with quality life.
Conclusion
Study results conclude that biofield treatment has significantly
altered the level of cytokines (IL-6 and TNF-α) in endometrium and
prostate cancer cell lines as compared to control. Mr. Trivedi’s biofield
treatment showed a significant reduction in IL-6 level in prostate
cancer cells (98.8%) and endometrium cancer cell (12%) as compared
to control. There was also a significant increase of TNF-α concentration
in both endometrium and prostate cancer cell lines. These data suggest
that biofield treatment has significant impact in altering the cancer
biomarkers especially two cytokine levels in both cancer cell lines.
Acknowledgement
Authors gratefully acknowledged to support of Trivedi science, Trivedi
testimonials and Trivedi master wellness in this research work.
Conflict of interest
The authors declare that they have no competing interests.
References
1. Mirkin S, Pickar JH (2015) Selective estrogen receptor modulators (SERMs): a
review of clinical data. Maturitas 80: 52-57.
2. Febbraro T, Lengyel E, Romero IL (2014) Old drug, new trick: repurposing
metformin for gynecologic cancers? Gynecol Oncol 135: 614-621.
3. Siufi DF, Siufi Neto J, Abrão MS, Favero G (2014) Lymphadenectomy in early
stage endometrial cancer: a critical review of the current literature. Tumori 100:
477-485.
4. Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, et al. (2006)
Carcinoma of the corpus uteri. FIGO 26th Annual Report on the results of
treatment in gynecological cancer. Int J Gynaecol Obstet 95: S105-S143.
5. Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, et al. (2006)
Randomized phase III trial of whole-abdominal irradiation versus doxorubicin
and cisplatin chemotherapy in advanced endometrial carcinoma: A gynecologic
oncology group study. J Clin Oncol 24: 36-44.
6. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer
J Clin 63: 11-30.
7. Huss WJ, Barrios RJ, Foster BA, Greenberg NM (2003) Differential expression
of specific FGF ligand and receptor isoforms during angiogenesis associated
with prostate cancer progression. Prostate 54: 8-16.
8. Joyce JA, Pollard JW (2009) Microenvironmental regulation of metastasis. Nat
Rev Cancer 9: 239-252.
9. Smith DS, Catalona WJ, Herschman JD (1996) Longitudinal screening for
prostate cancer with prostate-specific antigen. JAMA 276: 1309-1315.
10. Daiter E, Pampfer S, Yeung YG, Barad D, Stanley ER, et al. (1992) Expression
of colony-stimulating factor-1 in the human uterus and placenta. J Clin
Endocrinol Metab 74: 850-858.
11. Kayl AE, Meyers CA (2006) Side-effects of chemotherapy and quality of life in
ovarian and breast cancer patients. Curr Opin Obstet Gynecol 18: 24-28.
12. Alvarez Secord A, Havrilesky LJ, Bae-Jump V, Chin J, Calingaert B, et al.
(2007) The role of multi-modality adjuvant chemotherapy and radiation in
women with advanced stage endometrial cancer. Gynecol Oncol 107: 285-291.
13. Bruzzone M, Miglietta L, Franzone P, Gadducci A, Boccardo F (2004)
Combined treatment with chemotherapy and radiotherapy in high-risk FIGO
stage III-IV endometrial cancer patients. Gynecol Oncol 93: 345-352.
14. Barnes PM, Bloom B, Nahin RL (2008) Complementary and alternative
medicine use among adults and children: United States, 2007. Natl Health Stat
Report : 1-23.
15. Garland SN, Valentine D, Desai K, Langer C, Evans T, et al. (2013)
Complementary and alternative medicine use and benefit finding among
cancer patients. J Altern Complement Med 19: 876-881.
16. Giasson M, Bouchard L (1998) Effect of therapeutic touch on the well-being of
persons with terminal cancer. J Holist Nurs 16: 383-398.
17. Peck SD1 (1998) The efficacy of therapeutic touch for improving functional
ability in elders with degenerative arthritis. Nurs Sci Q 11: 123-132.
18. Turner JG, Clark AJ, Gauthier DK, Williams M (1998) The effect of therapeutic
touch on pain and anxiety in burn patients. J Adv Nurs 28: 10-20.
19. Yount G, Patil S, Dave U, Alves-dos-Santos L, Gon K, et al. (2013) Evaluation
of biofield treatment dose and distance in a model of cancer cell death. J Altern
Complement Med 19: 124-127.
20. Chen KW (2008) Inhibitory effects of bio-energy therapies on cancer growth.
World Sci Tech Modern Trad Chin Med 10: 144-152.
21. Shinde V, Sances F, Patil S, Spence A (2012) Impact of biofield treatment on
growth and yield of lettuce and tomato. Aust J Basic Appl Sci 6: 100-105.
22. Sances F, Flora E, Patil S, Spence A, Shinde V (2013) Impact of biofield
treatment on ginseng and organic blueberry yield. AGRIVITA J Agri Sci 35:
22-29.
23. Dabhade VV, Tallapragada RR, Trivedi MK (2009) Effect of external energy
on atomic, crystalline and powder characteristics of antimony and bismuth
powders. Bull Mat Sci 32: 471-479.
24. Trivedi MK, Patil S, Tallapragada RM (2012) Thought Intervention through
biofield changing metal powder characteristics experiments on powder
characterisation at a PM Plant, Springer Berlin Heidelberg, Editor: Wei Deng,
Lecture Notes in Electrical Engineering-Future Control and Automation 173:
247-252.
25. Trivedi MK, Patil S (2008) Impact of an external energy on Staphylococcus
epidermis [ATCC-13518] in relation to antibiotic susceptibility and biochemical
reactions-an experimental study. J Accord Integr Med 4: 230-235.
26. Trivedi MK, Patil S (2008) Impact of an external energy on Yersinia enterocolitica
[ATCC-23715] in relation to antibiotic susceptibility and biochemical reactions:
an experimental study. Internet J Alternat Med 6: 13.
27. Trivedi MK, Bhardwaj Y, Patil S, Shettigar H, Bulbule A (2009) Impact of an
external energy on Enterococcus faecalis [ATCC-51299] in relation to antibiotic
susceptibility and biochemical reactions-an experimental study. J Accord Integr
Med 5: 119-130.
28. Stephens JC, Larkins A, James RF, Rathbone BJ (1996) Production of a
monoclonal antibody against the 128 kDa (CagA) protein of Helicobacter pylori.
J Immunol Methods 190: 163-169.
29. Whitcomb BW, Perkins NJ, Albert PS, Schisterman EF (2010) Treatment of
batch in the detection, calibration, and quantification of immunoassays in large-
scale epidemiologic studies. Epidemiology 21 Suppl 4: S44-50.
30. Running A (2015) Decreased Cortisol and Pain in Breast Cancer: Biofield
Therapy Potential. Evid Based Complement Alternat Med 2015: 870640.
31. Yount G, Patil S, Dave U, Alves-dos-Santos L, Gon K, et al. (2013) Evaluation
of biofield treatment dose and distance in a model of cancer cell death. J Altern
Complement Med 19: 124-127.
32. Monzillo E, Gronowicz G (2011) New insights on therapeutic touch: a discussion
of experimental methodology and design that resulted in significant effects on
normal human cells and osteosarcoma. Explore (NY) 7: 44-51.
33. Gronowicz GA, Jhaveri A, Clarke LW, Aronow MS, Smith TH (2008)
Therapeutic touch stimulates the proliferation of human cells in culture. J Altern
Complement Med 14: 233-239.
34. Renard N, Lienard D, Lespagnard L, Eggermont AMM, Heimann R, et al. (1994)
Early endothelium activation and polymorphonuclear cell invasion precede
specific necrosis of human melanoma and sarcoma treated by intravascular
high-dose tumour necrosis factor alpha (rTNF alpha). Int J Cancer 57: 656-663.
35. Seo KH, Lee HS, Jung B, Ko HM, Choi JH, et al. (2004) Estrogen enhances
angiogenesis through a pathway involving platelet-activating factor-mediated
nuclear factor-kB activation. Cancer Res 64: 6482-6488.
5. Citation: Trivedi MK, Patil S, Shettigar H, Gangwar M, Jana S (2015) In Vitro Evaluation of Biofield Treatment on Cancer Biomarkers Involved in
Endometrial and Prostate Cancer Cell Lines. J Cancer Sci Ther 7: 253-257. doi:10.4172/1948-5956.1000358
J Cancer Sci Ther
ISSN: 1948-5956 JCST, an open access journal Volume 7(7) 253-257 (2015) - 257
36. SlaterM,CooperM,MurphyCR(2006)Humangrowthhormoneandinterleukin-6
are upregulated in endometriosis and endometrioid adenocarcinoma. Acta
Histochem 108: 13-18.
37. Chen T, Wang LH, Farrar WL (2000) Interleukin 6 activates androgen receptor-
mediated gene expression through a signal transducer and activator of
transcription 3-dependent pathway in LNCaP prostate cancer cells. Cancer
Res 60: 2132-2135.
38. Drachenberg DE, Elgamal AA, Rowbotham R, Peterson M, Murphy GP (1999)
Circulating levels of interleukin-6 in patients with hormone refractory prostate
cancer. Prostate 41: 127-133.
39. Shen MX (1997) Qigong is an effective way to defeat cancer. China Qigong
Science 5: 8-10.
40. Chen K, Yeung R (2002) Exploratory studies of Qigong therapy for cancer in
China. Integr Cancer Ther 1: 345-370.
Citation: Trivedi MK, Patil S, Shettigar H, Gangwar M, Jana S (2015) In
Vitro Evaluation of Biofield Treatment on Cancer Biomarkers Involved in
Endometrial and Prostate Cancer Cell Lines. J Cancer Sci Ther 7: 253-257.
doi:10.4172/1948-5956.1000358